Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
The Tohoku Journal of Experimental Medicine|July 30, 2011
The potential inhibitory effect of revaprazan, an acid pump antagonist, on anticoagulation with warfarinJae-Woo Jung, Hye-Ryun Kang, Jae-Woo Kwon, et al.
Clinical Therapeutics|August 28, 2012
Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover studyNamyi Gu, JaeWoo Kim, Kyoung Soo Lim, et al.
Translational and Clinical Pharmacology|January 13, 2025
Research on unintroduced new drugs in South Korea from 2011 to 2020: approaches to prioritization and strategyHyewon Jeon, Sang-In Park, Sang-Won Lee, et al.
Human Pathology|October 8, 2014
Invasive Paget disease of the breast: 20 years of experience at a single institutionHyun-Woo Lee, Tae Eun Kim, Soo Youn Cho, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 18, 2012
Comparison of pharmacokinetics between sarpogrelate hydrochloride immediate-release formulation and controlled-release formulationTae-Eun Kim, Jung-Ryul Kim, Jin Ah Jung, et al.
Cancers|July 9, 2022
Comprehensive Comparison of 22C3 and SP263 PD-L1 Expression in Non-Small-Cell Lung Cancer Using Routine Clinical and Conditioned ArchivesSue Youn Kim, Tae-Eun Kim, Chan Kwon Park, et al.
Clinical Therapeutics|September 5, 2012
Evaluation of the pharmacokinetics, food effect, pharmacodynamics, and tolerability of DA-1229, a dipeptidyl peptidase IV inhibitor, in healthy volunteers: first-in-human studyTae-Eun Kim, Kyoung Soo Lim, Min Kyu Park, et al.
Pharmacology|June 20, 2015
Multiple-Dose Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety in Healthy Subjects: A Comparison of Controlled-Release Sarpogrelate and Immediate-Release SarpogrelateSoo-Yun Lee, Jung-Ryul Kim, Jin Ah Jung, et al.
Annals of the American Thoracic Society|December 25, 2015
Preferences of Current and Potential Patients and Family Members Regarding Implementation of Electronic Communication Portals in Intensive Care UnitsSamuel M Brown, Sigall K Bell, Stephanie D Roche, et al.
Clinical Drug Investigation|May 8, 2014
Tolerability and pharmacokinetics of lobeglitazone, a novel peroxisome proliferator-activated receptor-γ agonist, after a single oral administration in healthy female subjectsMin Kyu Park, Tae-Eun Kim, JaeWoo Kim, et al.
Pageof 21